Saltar al contenido
Merck

Frequent involvement of chromatin remodeler alterations in gastric field cancerization.

Cancer letters (2014-12-03)
Hideyuki Takeshima, Tohru Niwa, Takamasa Takahashi, Mika Wakabayashi, Satoshi Yamashita, Takayuki Ando, Yuki Inagawa, Hirokazu Taniguchi, Hitoshi Katai, Toshiro Sugiyama, Tohru Kiyono, Toshikazu Ushijima
RESUMEN

A field for cancerization, or a field defect, is formed by the accumulation of genetic and epigenetic alterations in normal-appearing tissues, and is involved in various cancers, especially multiple cancers. Epigenetic alterations are frequently present in chronic inflammation-exposed tissues, but information on individual genes involved in the formation of a field defect is still fragmental. Here, using non-cancerous gastric tissues of cancer patients, we isolated 16 aberrantly methylated genes, and identified chromatin remodelers ACTL6B and SMARCA1 as novel genes frequently methylated in non-cancerous tissues. SMARCA1 was expressed at high levels in normal gastric tissues, but was frequently silenced by aberrant methylation in gastric cancer cells. Moreover, somatic mutations of additional chromatin remodelers, such as ARID1A, SMARCA2, and SMARCA4, were found in 30% of gastric cancers. Mutant allele frequency suggested that the majority of cancer cells harbored a mutation when present. Depletion of a chromatin remodeler, SMARCA1 or SMARCA2, in cancer cell lines promoted their growth. These results showed that epigenetic and genetic alterations of chromatin remodelers are induced at an early stage of carcinogenesis and are frequently involved in the formation of a field defect.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Cloroformo, contains 100-200 ppm amylenes as stabilizer, ≥99.5%
Sigma-Aldrich
Cloroformo, HPLC Plus, for HPLC, GC, and residue analysis, ≥99.9%, contains amylenes as stabilizer
Sigma-Aldrich
Cloroformo, suitable for HPLC, ≥99.8%, contains 0.5-1.0% ethanol as stabilizer
Sigma-Aldrich
Cloroformo, contains ethanol as stabilizer, ACS reagent, ≥99.8%
Sigma-Aldrich
Fenol solution, Equilibrated with 10 mM Tris HCl, pH 8.0, 1 mM EDTA, BioReagent, for molecular biology
Sigma-Aldrich
Cloroformo, ReagentPlus®, ≥99.8%, contains 0.5-1.0% ethanol as stabilizer
Sigma-Aldrich
Cloroformo, contains amylenes as stabilizer, ACS reagent, ≥99.8%
Sigma-Aldrich
Cloroformo, HPLC Plus, for HPLC, GC, and residue analysis, ≥99.9%, contains 0.5-1.0% ethanol as stabilizer
Sigma-Aldrich
Fenol solution, BioReagent, Saturated with 0.01 M citrate buffer, pH 4.3 ± 0.2, for molecular biology
Sigma-Aldrich
Fenol, ≥99%
Sigma-Aldrich
Cloroformo, ACS spectrophotometric grade, ≥99.8%, contains 0.5-1.0% ethanol as stabilizer
Sigma-Aldrich
Cloroformo, biotech. grade, ≥99.8%, contains 0.5-1.0% ethanol as stabilizer
Sigma-Aldrich
Cloroformo, contains ethanol as stabilizer, meets analytical specification of BP, 99-99.4% (GC)
Sigma-Aldrich
Fenol, puriss. p.a., ACS reagent, reag. Ph. Eur., 99.0-100.5%
Sigma-Aldrich
Fenol, natural, 97%, FG
USP
Fenol, United States Pharmacopeia (USP) Reference Standard
Supelco
Fenol solution, certified reference material, 500 μg/mL in methanol
Sigma-Aldrich
Fenol, BioUltra, for molecular biology, TE-saturated, ~73% (T)
Sigma-Aldrich
Cloroformo, anhydrous, contains amylenes as stabilizer, ≥99%
Sigma-Aldrich
Fenol solution, ≥89.0%
Supelco
Fenol solution, 5000 μg/mL in methanol, certified reference material
Sigma-Aldrich
Fenol, for molecular biology
Sigma-Aldrich
Cloroformo, ≥99%, PCR Reagent, contains amylenes as stabilizer
Supelco
Cloroformo, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Cloroformo, analytical standard
Supelco
Fenol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Fenol, BioXtra, ≥99.5% (GC)
Sigma-Aldrich
Fenol, puriss., ≥99.5% (GC), meets analytical specification of Ph. Eur., BP, USP, crystalline (detached)
Sigma-Aldrich
Fenol, contains hypophosphorous as stabilizer, loose crystals, ACS reagent, ≥99.0%
Sigma-Aldrich
Fenol, unstabilized, ReagentPlus®, ≥99%